The Ensign Group, Inc. (NASDAQ:ENSG) Stock Rated "Moderate Buy" by Wall Street Brokerages

Key Points

• Analyst sentiment is moderately positive: Four of six brokerages rate The Ensign Group a buy, while two recommend holding the stock. The average 12-month price target is $216.25 versus a recent price of $171.78.
• Operating performance and expansion remain strong: Quarterly revenue increased 16.7% year over year to $1.44 billion, while EPS of $1.92 exceeded estimates. Recent acquisitions in Florida, Colorado, and Washington add approximately 2,000 skilled-nursing beds.
• Investors face potential legal and integration risks: Law firms have announced investigations into possible securities-law violations, while the multi-state expansion could create staffing, integration, and financial challenges.

The Ensign Group, Inc. (NASDAQ:ENSG - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six brokerages that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $216.25.

A number of research analysts recently commented on ENSG shares. Truist Financial boosted their price target on The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a research note on Thursday, July 30th. Wall Street Zen upgraded shares of The Ensign Group from a "hold" rating to a "buy" rating in a research report on Saturday. Weiss Ratings reiterated a "buy (b-)" rating on shares of The Ensign Group in a research report on Friday, September 11th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $228.00 target price on shares of The Ensign Group in a research note on Tuesday, July 28th.

Insider Activity at The Ensign Group

In other news, Director John Agwunobi sold 392 shares of the firm's stock in a transaction that occurred on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the sale, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. This trade represents a 3.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.00% of the company's stock.

Hedge Funds Weigh In On The Ensign Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in The Ensign Group during the 2nd quarter worth $937,218,000. Wasatch Advisors LP raised its position in The Ensign Group by 10.7% in the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company's stock valued at $365,215,000 after purchasing an additional 220,329 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of The Ensign Group by 20.6% during the fourth quarter. Franklin Resources Inc. now owns 630,380 shares of the company's stock valued at $109,812,000 after purchasing an additional 107,689 shares in the last quarter. Clark Capital Management Group Inc. grew its holdings in shares of The Ensign Group by 3.1% during the fourth quarter. Clark Capital Management Group Inc. now owns 513,857 shares of the company's stock worth $89,514,000 after purchasing an additional 15,328 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of The Ensign Group by 7.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 457,667 shares of the company's stock worth $92,220,000 after purchasing an additional 30,521 shares during the last quarter. Institutional investors own 96.12% of the company's stock.

Key Headlines Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Ensign acquired skilled nursing and senior living operations in Florida, Colorado, and Washington, adding roughly 2,000 skilled nursing beds and expanding its portfolio to 418 healthcare operations across 18 states. The move strengthens its geographic footprint and could provide additional revenue and earnings growth if the facilities are integrated successfully. The Ensign Group Expands Portfolio with Acquisitions in Washington, Florida and Colorado
• Positive Sentiment: The Florida expansion gives Ensign an entry into a large healthcare market, while the Washington and Colorado transactions deepen its presence in existing regions. Several facilities are tied to long-term triple-net leases, and Ensign also acquired real estate assets for five facilities through its captive REIT. The Ensign Group Announces Expansion Into Florida
• Positive Sentiment: Recent operating momentum remains favorable: quarterly revenue rose about 17% year over year to approximately $1.44 billion, and earnings per share exceeded consensus estimates. Zacks also highlighted ENSG as a strong growth stock, reinforcing the view that acquisitions and organic performance can support future results. Here's Why Ensign Group is a Strong Growth Stock
• Neutral Sentiment: The rapid multi-state expansion could increase integration, staffing, and financial obligations, particularly because Ensign often targets facilities requiring operational improvement. Investors will look for details on acquisition costs, occupancy, margins, and the pace of earnings contribution.
• Negative Sentiment: Rosen Law Firm and Kaplan Fox announced investigations into potential securities-law violations, alleging that Ensign may have issued materially misleading business information. The announcements do not establish wrongdoing, but they create legal, reputational, and potential financial risks for shareholders. Rosen Law Firm Securities Class Action Investigation

The Ensign Group Stock Performance

NASDAQ ENSG opened at $171.78 on Monday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $10.01 billion, a P/E ratio of 26.92, a P/E/G ratio of 1.63 and a beta of 0.66. The Ensign Group has a 12-month low of $141.58 and a 12-month high of $218.00. The firm has a 50-day moving average price of $176.65 and a two-hundred day moving average price of $177.49.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last released its quarterly earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the previous year, the business earned $1.59 earnings per share. The firm's quarterly revenue was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Analysts anticipate that The Ensign Group will post 7.04 earnings per share for the current year.

The Ensign Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, October 31st. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.0650 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $0.26 annualized dividend and a yield of 0.2%. The Ensign Group's payout ratio is presently 4.08%.

The Ensign Group Company Profile

The Ensign Group, Inc NASDAQ: ENSG is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.

The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.